Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Cox

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The Dental Register|March 11, 2021
The Elevator-Its Principle and Utility in ExtractionEdward Cox
The New England Journal of Medicine|August 21, 2014
FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosisEdward Cox, Katherine Laessig
The New England Journal of Medicine|November 4, 2009
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenzaDebra Birnkrant, Edward Cox
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2015
Editorial Commentary: A Collaborative Model for Endpoint Development: Advancing the Science of Antibacterial Drug Clinical TrialsJoseph G Toerner, Edward Cox
The New England Journal of Medicine|February 21, 2019
Needed: Antimicrobial DevelopmentEdward Cox, Sumathi Nambiar, Lindsey Baden
The New England Journal of Medicine|December 4, 2014
Evaluating Ebola therapies--the case for RCTsEdward Cox, Luciana Borio, Robert Temple
The New England Journal of Medicine|August 6, 2015
Combating Emerging Threats--Accelerating the Availability of Medical TherapiesLuciana Borio, Edward Cox, Nicole Lurie
Pharmacoeconomics - Open|October 19, 2018
Strimvelis<sup>®</sup> for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology EvaluationEmily South, Edward Cox, Nick Meader, et al.
BMJ Mental Health|January 27, 2026
Is it time for mental health services to invest in neurostimulation? An economic evaluation of transcranial magnetic stimulation therapies for the treatment of moderate to severe treatment-resistant depression in the UKEdward Cox, Jing Ma, Cristina Roadevin, et al.
The New England Journal of Medicine|April 20, 2007
Ketek--the FDA perspectiveJanice Soreth, Edward Cox, Sandra Kweder, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The Dental Register|March 11, 2021
The Elevator-Its Principle and Utility in ExtractionEdward Cox
The New England Journal of Medicine|August 21, 2014
FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosisEdward Cox, Katherine Laessig
The New England Journal of Medicine|November 4, 2009
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenzaDebra Birnkrant, Edward Cox
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2015
Editorial Commentary: A Collaborative Model for Endpoint Development: Advancing the Science of Antibacterial Drug Clinical TrialsJoseph G Toerner, Edward Cox
The New England Journal of Medicine|February 21, 2019
Needed: Antimicrobial DevelopmentEdward Cox, Sumathi Nambiar, Lindsey Baden
The New England Journal of Medicine|December 4, 2014
Evaluating Ebola therapies--the case for RCTsEdward Cox, Luciana Borio, Robert Temple
The New England Journal of Medicine|August 6, 2015
Combating Emerging Threats--Accelerating the Availability of Medical TherapiesLuciana Borio, Edward Cox, Nicole Lurie
Pharmacoeconomics - Open|October 19, 2018
Strimvelis<sup>®</sup> for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology EvaluationEmily South, Edward Cox, Nick Meader, et al.
BMJ Mental Health|January 27, 2026
Is it time for mental health services to invest in neurostimulation? An economic evaluation of transcranial magnetic stimulation therapies for the treatment of moderate to severe treatment-resistant depression in the UKEdward Cox, Jing Ma, Cristina Roadevin, et al.
The New England Journal of Medicine|April 20, 2007
Ketek--the FDA perspectiveJanice Soreth, Edward Cox, Sandra Kweder, et al.
Pageof 4